- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03609411
Splenectomy During Whole Liver Transplantation
July 31, 2018 updated by: Hospices Civils de Lyon
Indications for splenectomy during whole liver transplantation remain controversial and splenectomy is often avoided because of common complications.
The objective is to evaluate specific complications of these combined procedures.
Study Overview
Detailed Description
Data on patients who underwent splenectomy during liver transplantation were retrospectively analyzed .
Participants underwent splenectomy as part of routine medical care.
Patients undergoing simultaneous liver transplantation and splenectomy were matched to a non-splenectomy group.
Study Type
Observational
Enrollment (Actual)
141
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lyon, France
- Hôpital de la Croix-Rousse
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Among the 906 liver transplantations performed between 1994 and 2013 at the Liver Transplant Department of the Croix-Rousse University Hospital, Lyon-France, all 47 liver transplantations with simultaneous splenectomy were included and compared to 94 transplant recipients without splenectomy after a 1:2 matching for gender, age at transplantation, year of liver transplantation, MELD score, platelet level and presence of hepatocellular carcinoma.
Description
Inclusion Criteria:
- Patients undergoing liver transplantation between 1994 and 2013
Exclusion Criteria:
- Data from living donor patients, split liver transplantation, patients with pre- or post-operative splenectomy in medical history, and patients under 16 years were excluded from analysis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Splenectomy
Patients undergoing liver transplantation with simultaneous splenectomy
|
Splenectomy was performed after hepatectomy, in an extra-hilar manner with manual ligation of splenic vessels.
Other Names:
|
Liver transplantation
Patients undergoing liver transplantation only
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
3-month post-operative mortality
Time Frame: At 3 months post surgery
|
At 3 months post surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Post-operative morbidity
Time Frame: 3 months post surgery
|
Incidence of portal-vein thrombosis within 3 months post liver transplantation
|
3 months post surgery
|
One-year mortality
Time Frame: One year after surgery
|
One year after surgery
|
|
Mortality at 5 years
Time Frame: Five years after surgery
|
Five years after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2015
Primary Completion (Actual)
January 1, 2017
Study Completion (Actual)
January 1, 2017
Study Registration Dates
First Submitted
July 17, 2018
First Submitted That Met QC Criteria
July 31, 2018
First Posted (Actual)
August 1, 2018
Study Record Updates
Last Update Posted (Actual)
August 1, 2018
Last Update Submitted That Met QC Criteria
July 31, 2018
Last Verified
July 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CRC_GHN_2018_002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on End Stage Liver Disease
-
Vanderbilt University Medical CenterEnrolling by invitationEnd Stage Liver DIseaseUnited States
-
Virginia Commonwealth UniversityCompletedEnd Stage Liver DIseaseUnited States
-
Guy's and St Thomas' NHS Foundation TrustKing's College LondonCompletedEnd-stage Liver DiseaseUnited Kingdom
-
Proteonomix, Inc.University of Medicine and Dentistry of New Jersey; NumodaUnknownEnd Stage Liver DIseaseUnited States
-
University of ZurichUniversity Ghent; University Hospital of Sao Paulo, BrazilCompleted
-
RenJi HospitalNot yet recruitingEnd Stage Liver DIsease
-
Mayo ClinicRecruiting
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Huashan HospitalRecruiting
-
Beijing Chao Yang HospitalUnknownLiver Transplantation | End Stage Liver DIseaseChina
Clinical Trials on Splenectomy
-
Beijing Friendship HospitalUnknownHemophagocytic LymphohistiocytosisChina
-
Children's Mercy Hospital Kansas CityWithdrawnIdiopathic Thrombocytopenic Purpura | Hereditary SpherocytosisUnited States
-
Yonsei UniversityTerminatedDuctal Adenocarcinoma | Left-sided Pancreatic CancerKorea, Republic of
-
Zhang LeiRecruitingThrombocytopenia | SplenectomyChina
-
Zagazig UniversityCompletedLaparoscopic Surgery
-
First Affiliated Hospital of Harbin Medical UniversityUnknownInfection | Gut Microbiota | Spleen InjuryChina
-
Tanta UniversityCompletedChildren | Laparoscopic Splenectomy | Benign Blood Diseases
-
Tecnologico de MonterreyCompletedArterial Splenic AneurysmMexico
-
Northern Jiangsu People's HospitalRecruitingCirrhosis, Liver | Splenectomy; StatusChina
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, JapanCompleted